Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.

Faghihi, Gita; Iraji, Fariba; Siadat, Amir Hossein; Saber, Mina; Jelvan, Minoo; Hoseyni, Maedeh Sadat

Faghihi, Gita; Iraji, Fariba; Siadat, Amir Hossein; Saber, Mina; Jelvan, Minoo; Hoseyni, Maedeh Sadat.

Afiliación

Faghihi G; Dermatology Department, Isfahan University of Medical Sciences, Isfahan, Iran.
Iraji F; Dermatology Department, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Siadat AH; Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Saber M; Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Jelvan M; Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Hoseyni MS; Isfahan University of Medical Sciences, Isfahan, Iran.

J Cosmet Dermatol ; 21(10): 4447-4453, 2022 Oct.

Article en En | MEDLINE | ID: mdl-35152531

Asunto(s)

Flutamida; Minoxidil; Humanos; Flutamida/uso terapéutico; Resultado del Tratamiento; Alopecia/diagnóstico; Alopecia/tratamiento farmacológico; Alopecia/inducido químicamente; Finasterida; Administración Tópica

Palabras clave

androgenetic alopecia; clinical trial; topical treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Flutamida / Minoxidil Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: J Cosmet Dermatol Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google